Wolverine Asset Management’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-1,000
Closed -$10.1K – 1874
2023
Q3
$10.1K Hold
1,000
– – ﹤0.01% 1467
2023
Q2
$12.5K Hold
1,000
– – ﹤0.01% 1364
2023
Q1
$11.7K Buy
+1,000
New +$12.7K ﹤0.01% 1428
2020
Q4
– Sell
-5,000
Closed -$183K – 1742
2020
Q3
$183K Hold
5,000
– – ﹤0.01% 1007
2020
Q2
$145K Buy
+5,000
New +$138K ﹤0.01% 1010

Other funds holding HCAT

Wolverine Asset Management's HCAT Position: Q4 2023 in Review

Wolverine Asset Management sold out of Health Catalyst (HCAT) in Q4 2023, closing a stake of 600 shares — an estimated $6.07K sold.

Wolverine Asset Management first reported a position in HCAT in Q3 2022 and held it in 4 quarters. The position peaked at $104K in Q3 2022. 167 funds tracked by Wall St. Rank hold HCAT as of Q4 2023.

  • Wolverine Asset Management reported no remaining Health Catalyst position as of Q4 2023 after selling out during the quarter.
  • Wolverine Asset Management sold 600 Health Catalyst shares in Q4 2023, an estimated $6.07K.
  • Wolverine Asset Management first reported a position in Health Catalyst in Q3 2022 and held it in 4 quarters.
  • Wolverine Asset Management's Health Catalyst position peaked at $104K in Q3 2022.
  • 167 funds tracked by Wall St. Rank held Health Catalyst as of Q4 2023.

Based on Wolverine Asset Management's 13F filing for Q4 2023, filed 1 Feb 2024.